Tumor targeting using anti-her2 immunoliposomes-Reference-Cited by-同舟云学术

Tumor targeting using anti-her2 immunoliposomes

Published:2001-07 Issue:1-3 Volume:74 Page:95-113
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Park J.W.,Kirpotin D.B.,Hong K.,Shalaby R.,Shao Y.,Nielsen U.B.,Marks J.D.,Papahadjopoulos D.,Benz C.C.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. The ErbB signaling network: receptor heterodimerization in development and cancer;Olayioye;EMBO J.,2000

2. ErbB2 overexpression in breast cancer: biology and clinical translation;Benz;J. Women’s Cancer,2000

3. Human breast cancer: correlation of relapse and survival with amplification of HER2/neu oncogene;Slamon;Science,1987

4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

5. The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer;Mitchell;Semin. Oncol.,1999

Cited by 304 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review;Human Immunology;2024-09

2. Immunoliposomes as a promising antiviral agent against SARS-COV-2;Доклады Российской академии наук. Науки о жизни;2024-07-05

3. Nano‐Micron Combined Hydrogel Microspheres: Novel Answer for Minimal Invasive Biomedical Applications;Macromolecular Rapid Communications;2024-02-24

4. Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2;Doklady Biochemistry and Biophysics;2024-01-07

5. Protein and peptide nanoparticles for drug delivery applications;Nanostructured Materials for Biomedical Applications;2024